What is Neuropace, Inc.'s tax on share settlement?

Neuropace, Inc. (NPCE) reported tax on share settlement of $176K in Q1 2026.

How has Neuropace, Inc.'s tax on share settlement changed year-over-year?

Neuropace, Inc.'s tax on share settlement decreased by 22.8% year-over-year, from $228K to $176K.

What is the long-term trend for Neuropace, Inc.'s tax on share settlement?

Over 3 years (2022 to 2025), Neuropace, Inc.'s tax on share settlement has grown at a 109.6% compound annual growth rate (CAGR), from $59K to $543K.

What does tax on share settlement mean?

Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.

Neuropace, Inc. NPCE Tax on Share Settlement

Tax on Share Settlement at other companies

ClearPoint NeuroCLPT

$1.99M+52.7%

Inspire Medical SystemsINSP

$7.59M-60.4%

Orthofix Medical Inc.OFIX

$264K-27.7%

Catalyst PharmaceuticalCPRX

$301K-53.1%

ITG

Integer HoldingsITGR

$9.04M-36.1%

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$22.1M-2.0%

Gross profit$18.0M+4.1%

Operating income-$5.6M-8.2%

Net income-$6.7M-1.5%

EPS (diluted)-$0.20+4.8%

Balance sheet

See full

Cash & equivalents$15.6M-42.4%

Total debt$70.5M-3.7%

Total equity$14.5M-40.4%

Total assets$98.9M-10.3%

Cash flow

See full

Operating cash flow-$5.9M+21.1%

CapEx$117.0K+216%

Free cash flow-$6.0M+20.0%

Valuation

See full

Market cap$557.77M+63.4%

Enterprise value$612.6M+58.1%

P/S5.6×+1.6×

Profitability

See full

Gross margin78.3%+3.5pp

Operating margin-16.8%-3.5pp

Net margin-21.7%-4.5pp

FCF margin-10.3%-3.5pp

Returns & leverage

See full

Return on equity-111.4%-13.1pp

Debt / equity4.9×+1.9×

Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuropace, Inc.'s tax on share settlement?: Neuropace, Inc. (NPCE) reported tax on share settlement of $176K in Q1 2026.
How has Neuropace, Inc.'s tax on share settlement changed year-over-year?: Neuropace, Inc.'s tax on share settlement decreased by 22.8% year-over-year, from $228K to $176K.
What is the long-term trend for Neuropace, Inc.'s tax on share settlement?: Over 3 years (2022 to 2025), Neuropace, Inc.'s tax on share settlement has grown at a 109.6% compound annual growth rate (CAGR), from $59K to $543K.
What does tax on share settlement mean?: Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.